Design, Synthesis, and Pharmacological Characterization of Novel Kappa Opioid Receptor Agonists via Isosteric Replacement Strategy for Inflammatory Pain
Nov 2026· Journal of Medicinal Chemistry· 0 citations· 94 references
TL;DR
Pharmacokinetic studies identified compound 10 as a P-glycoprotein substrate with limited brain exposure, consistent with a CNS-sparing profile and preferentially peripheral activity, and was identified as a KOR-mediated antinociception candidate.
Abstract
Pain management remains a critical challenge, with mu opioid receptor (MOR) agonists carrying significant risks of respiratory depression and addiction. Kappa opioid receptor (KOR) agonists offer a promising alternative, but centrally mediated adverse effects such as sedation and dysphoria limit their clinical utility. We synthesized 24 nalfurafine analogues via isosteric replacement of its furan side chain with diverse aromatic moieties. All compounds retained high KOR binding affinity and full agonist efficacy, with most displaying G-protein biased signaling. Compound 10, prioritized based on its pharmacological profile, was inactive in thermal nociception assays at doses up to 10 mg/kg, yet produced potent, KOR-mediated antinociception in the acetic acid writhing assay (ED50 = 0.009 mg/kg) and attenuated colonic hypersensitivity in a TNBS-induced colitis model of chronic visceral pain, without significant hypolocomotion. Pharmacokinetic studies identified compound 10 as a P-glycoprotein substrate with limited brain exposure, consistent with a CNS-sparing profile and preferentially peripheral activity.
Opioid peptide hybrids are multifunctional molecules in which an opioid pharmacophore is covalently integrated with a second opioid or non-opioid pharmacophore within a single molecular entity. Their development is driven by a major challenge in analgesic pharmacotherapy: although μ-opioid receptor (MOR) agonists remai...
Igor Cecherz, Jakub Waśkiewicz, Alicja Dudek et al.· Pharmaceuticals· 0 citations
Opioids are effective for severe pain but are limited by adverse effects and the risk of opioid use disorder (OUD), while non-opioid analgesics may provide insufficient relief. Neurotensin (NT), an endogenous neuropeptide, has attracted interest as a potential analgesic, with encouraging findings mainly from preclinica...
Fei Xu, N. Sudhan, Ke Peng et al.· Neuroscience and Biobehavior...· 0 citations
The goal of this narrative literature review was to compile the available data on NOP receptor-targeted analgesics, with a focus on dual NOP/MOP agonists and cebranopadol.
I. Shehata, Manar Ahmed Kamal, Taha Muhammad Makki et al.· Journal of Clinical Medicine· 0 citations
κ-Opioid receptor (KOR) agonists are promising candidates for analgesic development, yet their clinical application is limited by on-target adverse effects such as sedation and dysphoria. Attenuating β-arrestin2 recruitment while retaining G-protein signaling has therefore attracted interest as a strategy for improving...
Ruburika Nagao, Keita Kajino, Ryoji Kise et al.· European journal of medicina...· 0 citations
LIT-01-144 is designed and characterized, a modified spexin analog incorporating N-terminal fluorocarbon functionalization to improve metabolic stability while preserving receptor selectivity, and demonstrated the potential of LIT-01-144 as a valuable tool for understanding GALR2-mediated mechanisms of pain modulation.
Yann Berthomé, Glenn-Marie Le Coz, V. Utard et al.· Biomedicine & pharmacotherap...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.